Targeting MEK is effective chemoprevention of hepatocellular carcinoma in TGF-alpha-transgenic mice.

MLA

Wentz, Sabrina C., et al. “Targeting MEK Is Effective Chemoprevention of Hepatocellular Carcinoma in TGF-Alpha-Transgenic Mice.” Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract, vol. 12, no. 1, Jan. 2008, pp. 30–37. EBSCOhost, https://doi.org/10.1007/s11605-007-0396-4.

APA

Wentz, S. C., Wu, H., Yip-Schneider, M. T., Hennig, M., Klein, P. J., Sebolt-Leopold, J., & Schmidt, C. M. (2008). Targeting MEK is effective chemoprevention of hepatocellular carcinoma in TGF-alpha-transgenic mice. Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract, 12(1), 30–37. https://doi.org/10.1007/s11605-007-0396-4

Chicago

Wentz, Sabrina C, Huangbing Wu, Michele T Yip-Schneider, Matthew Hennig, Patrick J Klein, Judith Sebolt-Leopold, and C Max Schmidt. 2008. “Targeting MEK Is Effective Chemoprevention of Hepatocellular Carcinoma in TGF-Alpha-Transgenic Mice.” Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract 12 (1): 30–37. doi:10.1007/s11605-007-0396-4.